The amino acid sequence of the acrosin-trypsin inhibitor HUSI-II from human seminal plasma is presented which unequivocally identifies HUSI-II as being of Kazal-type. In addition, the HUSI-II sequence shows a striking similarity to the middle part of glycoprotein hormone p-subunits thus revealing a hitherto unknown structural and evolutionary relationship between Kazal-type inhibitors and glycoprotein hormones.
INTRODUCTION
Kazal-type inhibitors are proteinaceous inhibitors of serine proteinases with amino acid sequences similar to the sequence of bovine pancreatic secretory trypsin inhibitor first described by Kazal et al. [1] . Inhibitors of Kazal-type have been detected in all vertebrates investigated. They are present in eggs of birds and amphibians and in many tissues and body fluids such as blood plasma, seminal plasma, seminal vesicles, pancreas, pancreatic juice, submandibular gland and saliva [2, 3) .
The only inhibitor of human origin which was proven by sequence comparison as being of Kazal-type is the pancreatic secretory trypsin inhibitor [4] . Another trypsin inhibitor, the trypsin-acrosin inhibitor HUSI-II from human seminal plasma [5] [6] [7] [8] has been suspected to be of Kazal-type like the inhibitors found in seminal fluids of boar [9] and buH [10, 11] . The final proof, however, the elucidation of the amino acid sequence of HUSI-II, has never been brought forth. We now report the amino acid sequence of HUSI-II which unequivocally identifies this polypeptide as a Kazal-type inhibitor. 
EXPERIMENTAL
The acrosin-trypsin inhibitor HUSI-II was isolated from a pool of human semina! plasma basically as described [6] [7] [8] . In brief: after centrifugation the cell-free human seminal plasma was ineubated with SP-Sephadex C-50 at low ionic strength at pH 5.4. The ion exchanger was washed and eluted in a column with a linear gradient of 0-1.0 M NaCI in 0.05 M ammonium acetate buffer, pH 5.4. Trypsin inhibitors were isolated from the eluate by affinity chromatography on immobilized trypsin and subsequently separated by gel filtration into two fractions, HUSI-I (now designated MPI [12] ) and HUSI-II. The HUSI-II preparation was separated by ion exchange chromatography on SP-Sephadex C-25 (sodium phosphate of ionic strength 0.01 and pH 6.1-7.3 in 0.19 molll NaCl) into at least 7 peaks of very similar, though not eompletely identical amino acid compositions. The two prevalent of these chromatographie forms, HUSI-II-5 and -6, were used for sequencing. Further purification of these forms and isolation of peptides obtained after reduction and carboxymethylation or treatment with pyroglutamyl peptidase [13] was achieved by reversed 'phase HPLC (butyl or octadecyl column, gradient of acetonitrile in O.IOJo trifluoroacetic acid). N-terminal pyroglutamic acid was removed from redueed, carboxymethylated inhibitor by treatment with pyroglutamyl peptidase (Boehringer, Mannheim) [13] . The amino acid sequences of purified peptides were determined employing an Applied Biosystems model 470A gas-phase sequencer with an on-line HPLC 120A system for identifieation of the PTH derivatives. The NBRF sequenee data bank (release 15) was searched by using the program MICROGENIE, version 5 (Beckman).
RESULTS AND DISCUSSION
In HUSI-Il-6 the reactive site peptide bond PI-P' I [14] (positions 23-24 in Fig. 1 ) is cleaved, therefore, two peptides were separated after reduction and alkylation. Their sequences correspond to positions 6-23 and [22] , human [4, 23] , porcine PSTI [24] ; BUSI-I, BUSI-IIA: bull semen inhibitor types I [10] and HA [11]; POSI: porcine semen inhibitor [9] . The amino acids which are identical to those of the HUSI-II sequence are shaded. The position of the PI residue [14] is marked by an arrow.
24-61 in Fig. 1 . Amino acid analysis of the inhibitor fraction HUSI-II-5 revealed that it contained 5 additional amino acids. The N-terminal amino acid of this fraction cannot be detected by automatic Edman degradation because it is blocked. After incubation with pyroglutamyl peptidase the sequence of the 11 Nterminal residues (2-12 in Fig. 1 ) was identified. The blocked N-terminus was obviously a pyroglutamyl residue most probably derived from an original glutaminyl. Sequence comparisons clearly demonstrated that HUSI-II is a Kazal-type serine proteinase inhibitor (Fig.  1) . The sequence of HUSI-II is more similar to the sequences of PSTIs than to those of inhibitors from seminal plasma of different species ( Fig. 1 and Table I ). An exception is an inhibitor isolated from guinea pig seminal vesicles (paper in preparation; sequence data not shown here), the sequence similarity of 50.80/0 to this inhibitor is significantly higher than to PSTIs.
A search for proteins with sequence similarities to HUSI-II disclosed a high degree of similarity between HUSI-I1 and the glycoprotein hormone ß-subunits (Fig.  2, Table 11 ). The family of glycoprotein hormones [15] is composed of chorionic gonadotropin, luteinizing hormone, follicle-stimulating hormone, and thyroidstimulating hormone. Within one species, all glycoprotein hormones share a common a-subunit, whereas the ß-subunits are similar but not identical and determine the biological specificity [15] .
The sequence similarity of HUSI-I1 to glycoprotein hormone ß-subunits, especially to hCGß and hLHß is strikingly high. The other known human Kazal-type inhibitor, hPSTI, shows a lower, but nevertheless clearly recognizable similarity to the ß-subunits which is of about the same order of magnitude as that of Kazaltype inhibitors of different species like the 3 domains of chicken ovomucoid (Table 11) . Presumably due to this lower degree of similarity the structural relationship between Kazal-type inhibitors and glycoprotein hormones had not been detected before.
One sequence segment extending over 7 amino acids (Fig. 2, numbers 17-23 in the top line) is absolutely identical in HUSI-II, hCGß and hLHß. To our knowledge an identical segment of this length has never been found before in apparently unrelated proteins.
The conservation of this 17-23 segment during evolution might indicate that this part of the molecule plays a functionally important role both in HUSI-II and in glycoprotein hormones. In fact, this can be taken for granted for HUSI-II since in Kazal-type inhibitors the corresponding segment includes the major part of the region of primary contact between inhibitor and proteinase in the complex (discussed in detail by Laskowski et al. [16] ). In addition, the C-terminal Arg of the 17-23 segment (position 23 in Fig. 2 ) represents the Pt residue [14] of the reactive inhibitor site of HUSI-I1, i. e. the residue primarily responsible for the specificity of the inhibitor. It has been shown that the side chain of the Pt residue is inserted into the specificity pocket of the proteinases when complexes with the cognate enzymes are formed [17, 18] . Though no special function has been assigned to the 17-23 segment of the glycoprotein hormone ß-subunits it is tempting to speculate that this part of the molecule might also be involved in a strong protein-protein interaction such as complex formation with either the a-subunit or the receptor. In this context it is especially interesting that proteinaceous proteinase inhibitors can prevent the binding of hCG to receptor [19, 20] . This finding might suggest that the 17-23 segment has a tertiary structure similar to that of proteinase inhibitors and is reacting with a binding site similar to that of proteinases, or it might directly combi ne with a proteinase necessary for the binding of the hormone to the receptor. The involvement of such a [15) . Lowercase bold letters in the HUSI-II sequence indicate that the same amino acid is found in at least one of the hormone sequences. The amino acids of the ß-subunit sequences which are identical to those of the HUSI-II sequence are shaded. The numbering in the top Hne represents the numbering of HUSI-II, the right column gives the residue numbers of the respective sequence. The position of the PI residue [14) is marked by an arrow. OMCHIl, -2, -3: first, second and third domain of chicken ovomucoid [21) ; AA, 070: number and percentage of identical amino acids (100070 = 56). The numbers below the names indicate which sections of the protein sequences were compared proteinase has been proposed [19] . On the other hand, it can be deduced that ß-subunits could act as proteinase inhibitors. However, in our preliminary experiments with hCGß no inhibitory effect on bovine trypsin could be detected (data not shown). Currently we are starting experiments to investigate whether HUSI-II can antagonize the binding of hCG to its receptor.
